WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced that two ...
SOUTH SAN FRANCISCO, Calif., Nov. 5, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced ...
LEXINGTON, Mass., Nov. 4, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced ...
Collaborative Presentations Showcase BostonGene’s AI-Driven Innovations in Molecular and Immunoprofiling as Essential for Advancing Cancer Therapies Through Microenvironment and Immune Cell ...
BostonGene Announces Ten Presentations at the 65th American Society of Hematology Annual Meeting & Exposition Presentations with Leading Institutions Reveal BostonGene’s AI-driven Molecular and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results